DeepAI AI Chat
Log In Sign Up

What Clinical Trials Can Teach Us about the Development of More Resilient AI for Cybersecurity

by   Edmon Begoli, et al.

Policy-mandated, rigorously administered scientific testing is needed to provide transparency into the efficacy of artificial intelligence-based (AI-based) cyber defense tools for consumers and to prioritize future research and development. In this article, we propose a model that is informed by our experience, urged forward by massive scale cyberattacks, and inspired by parallel developments in the biomedical field and the unprecedentedly fast development of new vaccines to combat global pathogens.


page 1

page 2

page 3

page 4


Clinical acceptance of software based on artificial intelligence technologies (radiology)

There is a methodological framework for the process of clinical trials o...

Recent Developments in AI and USPTO Open Data

The USPTO disseminates one of the largest publicly accessible repositori...

Use of Artificial Intelligence Techniques / Applications in Cyber Defense

Nowadays, considering the speed of the processes and the amount of data ...

Integrating Artificial Intelligence into Weapon Systems

The integration of Artificial Intelligence (AI) into weapon systems is o...

Turbulence on the Global Economy influenced by Artificial Intelligence and Foreign Policy Inefficiencies

It is said that Data and Information are the new oil. One, who handles t...

The State of AI Ethics Report (June 2020)

These past few months have been especially challenging, and the deployme...

Towards Launching AI Algorithms for Cellular Pathology into Clinical Pharmaceutical Orbits

Computational Pathology (CPath) is an emerging field concerned with the ...